These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16932267)

  • 1. Are LDL subclass measurements clinically relevant?
    Stein EA
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):120-1. PubMed ID: 16932267
    [No Abstract]   [Full Text] [Related]  

  • 2. Atherogenic lipoprotein subprofiling.
    Ellington AA; Kullo IJ
    Adv Clin Chem; 2008; 46():295-317. PubMed ID: 19004193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment.
    Davidson MH
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1582-3. PubMed ID: 18716322
    [No Abstract]   [Full Text] [Related]  

  • 4. [Measurement of apolipoproteins is better than routinely measured traditional lipids].
    Kallner A; Estonius M
    Lakartidningen; 2006 Mar 8-14; 103(10):753-6, 758. PubMed ID: 16610202
    [No Abstract]   [Full Text] [Related]  

  • 5. The insulin resistance-dyslipidemia syndrome: the most prevalent cause of coronary artery disease?
    Després JP
    CMAJ; 1993 Apr; 148(8):1339-40. PubMed ID: 8462056
    [No Abstract]   [Full Text] [Related]  

  • 6. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome.
    Grundy SM
    Circulation; 1997 Jan; 95(1):1-4. PubMed ID: 8994405
    [No Abstract]   [Full Text] [Related]  

  • 7. LDL cholesterol. New measurements of risk.
    Mayo Clin Health Lett; 2011 May; 29(5):1-3. PubMed ID: 21656931
    [No Abstract]   [Full Text] [Related]  

  • 8. [Total variation of LDL-cholesterol and apolipoprotein B/ Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
    Coşkun A
    Anadolu Kardiyol Derg; 2007 Sep; 7(3):331-2; author reply 332. PubMed ID: 17785232
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
    Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced lipoprotein testing: recommendations based on current evidence.
    Lau JF; Smith DA
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):1-31. PubMed ID: 19217510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease.
    Miller M; Ginsberg HN; Schaefer EJ
    Am J Cardiol; 2008 Apr; 101(7):1003-8. PubMed ID: 18359322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond LDL cholesterol levels.
    Johns Hopkins Med Lett Health After 50; 2007 Jun; 19(4):7. PubMed ID: 17644849
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased ApoB in small dense LDL particles predicts premature coronary artery disease.
    Brunzell JD
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):474-5. PubMed ID: 15731485
    [No Abstract]   [Full Text] [Related]  

  • 14. Which lipid measures are prognostic indicators of cardiovascular disease in women?
    Oettgen P
    Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):190-1. PubMed ID: 16932280
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?
    Karp I; Abrahamowicz M; Fortin PR; Pilote L; Neville C; Pineau CA; Esdaile JM
    Arthritis Rheum; 2008 Feb; 59(2):169-75. PubMed ID: 18240259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study.
    Holme I; Høstmark AT; Anderssen SA
    J Intern Med; 2007 Aug; 262(2):235-43. PubMed ID: 17645591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A1 and B.
    Sniderman AD; Marcovina SM
    Clin Lab Med; 2006 Dec; 26(4):733-50. PubMed ID: 17110237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoproteins A-I and B-markers in coronary risk evaluation.
    Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
    Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of apolipoprotein B and low density lipoprotein with cardiovascular risk factors in the Thai population.
    Krittayaphong R; Chotinaiwatarakul C; Kangkagate C; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S1-7. PubMed ID: 17722296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.